Another Round of Coronavirus Cases Puts This Biotech ETF in Focus
June 29, 2020 at 12:45 PM EDT
Already one of the ETFs at the center of the coronavirus investment thesis, the ALPS Medical Breakthroughs ETF (SBIO) could be poised for more upside as the U.S. grapples with a second wave of the respiratory illness. SBIO focuses on small- and mid-cap companies that have one or more drugs in...